249 related articles for article (PubMed ID: 26696395)
21. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
22. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
Suryawanshi P; Bagul R; Shete A; Thakar M
Front Immunol; 2021; 12():663919. PubMed ID: 33995393
[TBL] [Abstract][Full Text] [Related]
23. Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.
Luo Z; Li Z; Martin L; Wan Z; Meissner EG; Espinosa E; Wu H; Yu X; Fu P; Julia Westerink MA; Kilby JM; Wu J; Huang L; Heath SL; Li Z; Jiang W
J Infect Dis; 2017 Jul; 216(1):82-91. PubMed ID: 28498953
[TBL] [Abstract][Full Text] [Related]
24. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection.
Ahmad R; Sindhu ST; Toma E; Morisset R; Vincelette J; Menezes J; Ahmad A
J Clin Immunol; 2001 May; 21(3):227-33. PubMed ID: 11403230
[TBL] [Abstract][Full Text] [Related]
26. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; ; Stratov I; Navis M; Kent SJ
Immunology; 2013 Feb; 138(2):116-23. PubMed ID: 23173935
[TBL] [Abstract][Full Text] [Related]
27. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
28. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
[TBL] [Abstract][Full Text] [Related]
29. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.
Parsons MS; Richard J; Lee WS; Vanderven H; Grant MD; Finzi A; Kent SJ
AIDS Res Hum Retroviruses; 2016; 32(10-11):1089-1096. PubMed ID: 27487965
[TBL] [Abstract][Full Text] [Related]
30. Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.
Tomescu C; Kroll K; Colon K; Papasavvas E; Frank I; Tebas P; Mounzer K; Reeves RK; Montaner LJ
Eur J Immunol; 2021 Aug; 51(8):2051-2061. PubMed ID: 34086344
[TBL] [Abstract][Full Text] [Related]
31. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
[TBL] [Abstract][Full Text] [Related]
32. Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant.
Phaahla NG; Lassaunière R; Da Costa Dias B; Waja Z; Martinson NA; Tiemessen CT
Front Immunol; 2019; 10():735. PubMed ID: 31024562
[TBL] [Abstract][Full Text] [Related]
33. Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
Isitman G; Chung AW; Navis M; Kent SJ; Stratov I
Virology; 2011 Mar; 412(1):110-6. PubMed ID: 21269655
[TBL] [Abstract][Full Text] [Related]
34. Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.
Forthal DN; Landucci G; Keenan B
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):553-61. PubMed ID: 11350669
[TBL] [Abstract][Full Text] [Related]
35. Deficient IL-2 Produced by Activated CD56
Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
Front Immunol; 2019; 10():1647. PubMed ID: 31379845
[No Abstract] [Full Text] [Related]
36. Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.
Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539449
[TBL] [Abstract][Full Text] [Related]
37. The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein.
Kramski M; Stratov I; Kent SJ
AIDS; 2015 Jan; 29(2):137-44. PubMed ID: 25396265
[TBL] [Abstract][Full Text] [Related]
38. Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.
Wren L; Parsons MS; Isitman G; Center RJ; Kelleher AD; Stratov I; Bernard NF; Kent SJ
PLoS One; 2012; 7(6):e38580. PubMed ID: 22701674
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.
Smalls-Mantey A; Doria-Rose N; Klein R; Patamawenu A; Migueles SA; Ko SY; Hallahan CW; Wong H; Liu B; You L; Scheid J; Kappes JC; Ochsenbauer C; Nabel GJ; Mascola JR; Connors M
J Virol; 2012 Aug; 86(16):8672-80. PubMed ID: 22674985
[TBL] [Abstract][Full Text] [Related]
40. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
